↓ Skip to main content

Heparanase activity in alveolar and embryonal rhabdomyosarcoma: implications for tumor invasion

Overview of attention for article published in BMC Cancer, August 2009
Altmetric Badge

Mentioned by

wikipedia
2 Wikipedia pages

Citations

dimensions_citation
29 Dimensions

Readers on

mendeley
24 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Heparanase activity in alveolar and embryonal rhabdomyosarcoma: implications for tumor invasion
Published in
BMC Cancer, August 2009
DOI 10.1186/1471-2407-9-304
Pubmed ID
Authors

Valentina Masola, Claudio Maran, Evelyne Tassone, Angelica Zin, Angelo Rosolen, Maurizio Onisto

Abstract

Rhabdomyosarcoma (RMS) is a malignant soft tissue sarcoma of childhood including two major histological subtypes, alveolar (ARMS) and embryonal (ERMS) RMS. Like other human malignancies RMS possesses high metastatic potential, more pronounced in ARMS than in ERMS. This feature is influenced by several biological molecules, including soluble factors secreted by tumor cells, such as heparanase (HPSE). HPSE is an endo-beta-D-glucuronidase that cleaves heparan sulphate proteoglycans.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 24 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 4%
United States 1 4%
Australia 1 4%
Unknown 21 88%

Demographic breakdown

Readers by professional status Count As %
Researcher 5 21%
Other 3 13%
Student > Ph. D. Student 3 13%
Professor > Associate Professor 3 13%
Student > Doctoral Student 2 8%
Other 5 21%
Unknown 3 13%
Readers by discipline Count As %
Agricultural and Biological Sciences 8 33%
Biochemistry, Genetics and Molecular Biology 4 17%
Chemistry 2 8%
Medicine and Dentistry 2 8%
Unspecified 1 4%
Other 1 4%
Unknown 6 25%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 July 2018.
All research outputs
#7,454,951
of 22,790,780 outputs
Outputs from BMC Cancer
#2,059
of 8,294 outputs
Outputs of similar age
#32,051
of 90,553 outputs
Outputs of similar age from BMC Cancer
#18
of 39 outputs
Altmetric has tracked 22,790,780 research outputs across all sources so far. This one is in the 44th percentile – i.e., 44% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,294 research outputs from this source. They receive a mean Attention Score of 4.3. This one has gotten more attention than average, scoring higher than 68% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 90,553 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 20th percentile – i.e., 20% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 39 others from the same source and published within six weeks on either side of this one. This one is in the 17th percentile – i.e., 17% of its contemporaries scored the same or lower than it.